* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Osteogenesis imperfecta, type II
Population genetics wikipedia , lookup
Genome evolution wikipedia , lookup
Gene expression profiling wikipedia , lookup
Genetic engineering wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene desert wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Gene expression programming wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Genome (book) wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Oncogenomics wikipedia , lookup
Gene nomenclature wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Frameshift mutation wikipedia , lookup
Designer baby wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Microevolution wikipedia , lookup
Bone Diseases Dr Derakhshandeh, PhD Marfan syndrome 2 Dominant negative mutations Dominant negative mutations: antimorphic mutations an altered gene product that acts antagonistically to the wild-type allele These mutations usually result in an altered molecular function (often inactive): Dominant or semi-dominant phenotype 3 Dominant negative mutations In humans: Marfan syndrome is an example of a dominant negative mutation occurring in an autosomal dominant disease the defective glycoprotein product of the fibrillin gene (FBN1): antagonizes the product of the normal allele 4 Marfan syndrome Fibrillin gene 5 Osteogenesis imperfecta 6 Osteogenesis imperfect 7 Definition Osteogenesis imperfecta: a congenital (present from birth) condition of abnormal fragility of the bones 8 Collagen Fibrillin in EM 9 Collagen in most tissues and organs is most plentiful in: dermis Tendon Cartilage and bone as a scaffolding for our bodies Controls cell shape broken bones regenerate and wounds heal 10 Collagens the fibrous protein constituent: Insoluble extracellular glycoprotein found in all animals the most abundant proteins in the human body 11 Primary Structure of Collagens The basic unit of collagens: a polypeptide consisting of the repeating sequence (Glycine (Gly) - X - Y)n X is often Proline (Pro) and Y is often hydroxyproline 12 Procollagen Type I The most common form of fibrillar collagen It is a major constituent of: bone and skin consists of a heterotrimer of: two alpha1(I) and one alpha2(I) chains 13 Procollagen Troprocollagen Collagens 14 Tertiary Structure 15 Extracellular processes of collagen synthesis Prockop & Kivirikko (1984) 16 OI, Genetic TYPE I OSTEOGENESIS IMPERFECTA WITH BLUE SCLERA Gene map locus 17q21.31-q22, 7q22.1 OI type I phenotype can be produced by mutation in either the COL1A1 gene or the COL1A2 gene 17 What is the official name of the COL1A1 gene? The official name of this gene is: “collagen, type I, alpha 1” COL1A1 is the gene's official symbol 18 Severity of disease Osteogenesis imperfecta: type II> type III> type IV> type I 19 Osteogenesis imperfecta type I 1:10 000 dominantly inherited (AD) Connective tissue disorder characterized mainly by bone fragility blue sclera 'functional null' alleles of COL1A1 on chromosome 17 or COL1A2 on chromosome 7 lead to reduced amounts of normal collagen I 20 21 22 23 24 Glycine Serin 25 What conditions are related to the COL1A1 gene? Ehles-Donlos syndrome (AD) Arthrochalasia: (Short stature, Hyper elasticity of skin, AR, Problem with healing, N-Terminal defect caused by mutations in the COL1A1 gene 26 Arthrochalasia 27 –The mutations in the COL1A1/2 gene –leave out a part of the pro-alpha1(I) chain that contains a segment used to attach one molecule to another –When this part of the protein is missing, the structure of type I collagen is compromised –Tissues that are rich in type I collagen: •such as the skin, bones, and tendons, are affected by this change 28 OI Type I Osteogenesis imperfecta is the most common disorder Mutations: inactivate one of the two copies of the COL1A1/2 gene: 29 OI Type I •The mutated copy of the gene does not produce any proalpha1/2(I) collagen chains •Because only one copy of the gene: •cells from people with this disorder make only half of the normal amount of type I collagen: •which results in bone fragility and other symptoms 30 OI Type II - caused by mutations in the COL1A1/2 gene Many different types of mutations in the COL1A1/2 gene: can cause osteogenesis imperfecta type II These mutations range: from missing pieces of the COL1A1/2 gene to amino acid substitutions in which the amino acid glycine is replaced by another amino acid in the protein strand 31 OI Type II Sometimes one end of the gene (called the C-terminus) is altered which interferes with the association of the protein strands All of these changes prevent the normal production of mature type I collagen which results in this severe condition, type II osteogenesis imperfecta 32 OI Type III - caused by mutations in the COL1A1/2 gene Mutations in the COL1A1/2 gene may result: unusable for collagen production Other mutations cause the amino acid glycine to be replaced by a different amino acid in the pro-alpha1(I) chain inhibits the essential interaction between protein chains 33 type III osteogenesis imperfecta inability of the altered procollagen strands These alterations negatively affect tissues that are rich in type I collagen such as the skin, bones, teeth (Dentinogenesis imperfecta), and tendons 34 OI Type (IV) caused by mutations in the COL1A1/2 gene Several different types of mutations in the COL1A1/2 gene cause osteogenesis imperfecta type IV missing pieces of the COL1A1/2 gene or changes in base pairs formation of the mature triple-stranded collagen molecule 35 OI Position effect (5’/3’- Mutation) Protein effect (Gly) Chain effect (aI/aII) 36 Where is the COL1A1 gene located? Cytogenetic Location: 17q21.3-q22.1 Molecular Location on chromosome 17 37 CLINICAL FEATURES Osteogenesis imperfecta: Characterized chiefly by multiple bone fractures, usually resulting from minimal trauma Affected individuals have blue sclerae, normal-near normal teeth, and normal or nearnormal stature 38 CLINICAL FEATURES Osteogenesis imperfecta: Fractures are rare in the neonatal period; fracture tendency is constant from childhood to puberty Often increases following menopause in women and after the sixth decade in men 39 CLINICAL FEATURES OI 40 CLINICAL FEATURES Fractures: heal rapidly with evidence of a callus formation and, with good orthopedic care, without deformity Hearing loss; occurs in about 50% of families beginning in the late teens to profound deafness, by the end of the fourth to fifth decade 41 CLINICAL FEATURES Radiologically: wormian bones are common but bone morphology is generally normal at birth Vertebral body morphology: in the adult is normal initially but often develops the classic 'cod-fish' appearance 42 EYES Individuals with OI type I have distinctly blue sclera which remain intensely blue throughout life The intensity of the blue fades with time: that these individuals may have sclerae of normal hue by adult life 43 EYES Hartikka et al. (2004) found that: patients with COL1A1 mutations more frequently had blue sclerae than those with COL1A2 mutations 44 CARDIOVASCULAR Mitral valve prolapse occurred in 18% (3 times the prevalence in unaffected relatives) 45 In EARS likely heterogeneous groups of patients with OI: about half of affected individuals have hearing loss that begins during the second decade as a conductive loss Audiometry showed hearing loss in 25 patients (59.5%) 46 EARS Hartikka et al. (2004) reported: No correlation was found between the mutated gene or mutation type and hearing pattern The authors interpreted this to mean that the basis of hearing loss in OI is complex and that it is a result of multifactorial 47 SKIN Skin elasticity OI type I increased elasticity in comparison to the type III patients 48 Causes, incidence, and risk factors All four types of OI are caused by defects in the amount or structure of Type 1 collagen an important part of the bone matrix 49 Prevention Genetic counseling: is recommended for prospective parents if one or both are affected by this disorder 50 Symptoms OI: • • • • all of the bones are abnormally weak The severity of the abnormality varies enormously from Type II OI which is usually lethal in infancy (or even before birth) Type I OI, which may be so mild that the diagnosis is not made, even in adulthood 51 Symptoms • not all people with OI will have blue sclerae or hearing loss All do have fragile bones, but not all people with OI actually ever break a bone penetrance of hearing loss is clearly age-dependent (Garretsen and Cremers, 1991) • 52 INHERITANCE Paternal age effect: for increased risk of new mutations has been documented although it appears to be considerably lower than, for example, in Achondroplasia Blumsohn et al. (2001) confirmed the presence of a small paternal age effect in apparently sporadic OI 53 CLINICAL FEATURES OII 54 OSTEOGENESIS IMPERFECTA CONGENITA, NEONATAL LETHAL FORM OSTEOGENESIS IMPERFECTA, TYPE II OI Gene map locus 17q21.31-q22, 7q22.1 55 OSTEOGENESIS IMPERFECTA, TYPE II 56 Osteogenesis imperfecta, type II: the most severe form of the disorder Infants with the disorder: have soft, fragile bones that may appear bent or crumpled Bones are easily broken and multiple fractures can occur even before birth The chest is narrow with short ribs and underdeveloped lungs 57 CLINICAL FEATURES OIII 58 OSTEOGENESIS IMPERFECTA, TYPE III Gene map locus 17q21.31-q22, 7q22.1 The causative mutation in most cases lies in one of the genes for type I collagen, COL1A1 or COL1A2 59 TYPE III OI 60 TYPE III OI People with the disorder are much shorter than average because the condition prevents bones from growing normally. Spinal curvature (scoliosis) and bone abnormalities often become progressively worse during childhood but tend to stabilize during adolescence These complications may shorten a person's lifespan by affecting heart and lung function Other signs and symptoms include a light blue tint to the part of the eyeball that is usually white , brittle and discolored teeth, loose joints, and, in some cases, hearing loss. 61 Gene Therapy Chamberlain et al. (2004) used adeno-associated virus vectors to disrupt mutant COL1A1 collagen genes in mesenchymal stem cells, from individuals with severe OI demonstrating successful gene targeting in adult human stem cells 62 CLINICAL FEATURES OI IV 63 OSTEOGENESIS IMPERFECTA, TYPE IV OI, TYPE IV OSTEOGENESIS IMPERFECTA WITH NORMAL SCLERAE Gene map locus 17q21.31-q22 64 OSTEOGENESIS IMPERFECTA, TYPE IV 65 Hypothesis more than one broken bone occurring in a single episode (multiple) present at birth occuring after only minor trauma a minority of people with OI never break a bone deformed or short extremities (such as leg deformities or arm deformities) deafness (conductive hearing loss may occur in adults) 66 Hypothesis Short stature tooth abnormalities low nasal bridge easy bruising bowed legs 67 Signs and tests A physical examination may confirm the presence of fractures, deformities, and other symptoms. Bone X-rays may show multiple healed fractures. Once the specific molecular diagnosis is known, family members can be tested by a DNA blood test. DNA testing on prenatal chorionic villus samples (CVS) can make the diagnosis during pregnancy. Severe OI is visible on prenatal 68 Achondroplasia 69 Achondroplasia Definition An inherited disorder of bone growth that causes the most common type of dwarfism 70 Achondroplasia its characteristic normal to largesized head shortened arms and legs (especially the upper arm) a normal-sized trunk and waddling gait 71 Achondroplasia Achondroplasia is inherited as an (AD) trait However, the majority of cases, approximately 80%, appear as spontaneous mutations If one parent has Achondroplasia, the infant has a 50% chance of inheriting the disorder If both parents have the condition, the infant's chances of being affected increase to 75% 72 Genetics of Achondroplasia 99% of the affected individuals: a single point mutation in the Fibroblast Growth Factor Receptor gene3 (FGFR 3) located on chromosome 4 glycine is substituted for arginine at codon 380 of FGFR 3 73 Family with compound heterozygosity for N540K and G380R mutations 74 Prevention Genetic counseling may be helpful for prospective parents: when one or both have Achondroplasia Because Achondroplasia arises as a spontaneous mutation: absolute prevention is not possible 75 Symptoms at birth: Short stature short limbs large appearing head Skeletal (limb) abnormality Abnormal hand appearance with persistent space between the long and ring fingers marked kyphosis and lordosis (spine curvatures) 76 kyphosis and lordosis 77 Symptoms Waddling gait prominent forehead (frontal bossing) increased inward curve of lower back increased outward curve of upper back making back appear slightly hunched (kyphosis) head appears disproportionately large for body bowed legs 78